Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Kodiak Sciences Inc KOD

Healthcare Biotechnology
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab, is a novel anti-vascular endothelial growth factor (anti... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:KOD)

Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2024 Financial Results

PR Newswire 13 days ago

Kodiak Sciences to Participate in Upcoming Investor Conferences

PR Newswire November 11, 2024

Kodiak Sciences to Present at Innovate Retina 2024

PR Newswire October 14, 2024

Kodiak Sciences to Host Investor R&D Day Today at 10:30am Eastern Time

PR Newswire September 23, 2024

Kodiak Sciences to Host Investor R&D Day on September 23, 2024 in New York City

PR Newswire September 17, 2024

Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results

PR Newswire August 14, 2024

Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences

PR Newswire May 29, 2024

Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results

PR Newswire May 15, 2024

Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy

PR Newswire May 13, 2024
View More News ››

Opinion & Analysis (NDAQ:KOD)

Kodiak Shares Soar on $225 Million Royalty Deal for Retinal Drug

Streetwise Reports December 3, 2019
View More Opinion ››

Bullboard Posts (NDAQ:KOD)

Kodiak Sciences to Participate in Upcoming Investor Conferen

JUST IN: $KOD Kodiak Sciences to Participate in Upcoming Investor ConferencesKodiak Sciences to Participate in Upcoming Investor...
whytestocks - November 11, 2024

Kodiak Sciences Announces Recent Business Highlights and Sec

BREAKING NEWS: $KOD Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial ResultsKodiak Sciences...
whytestocks - August 14, 2024

THE UNRAVELLING OF KODIAK SCIENCES

$KOD   Kodiak Sciences, Inc. (NASDAQ: KOD), a clinical-stage biotechnology Company focused on creating novel therapeutics for...
AviseAnalytics - February 25, 2022

nice trend

TJPatrol1 - June 10, 2020
View more Bullboard ››

Freegold Ventures Limited

Freegold Ventures Limited

Freegold Ventures Limited is a Canada-based company focused on exploration in Alaska. The Company holds Golden Summit Gold ...
View More »